These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3417618)

  • 1. Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men.
    Ciraulo DA; Barnhill JG; Greenblatt DJ; Shader RI; Ciraulo AM; Tarmey MF; Molloy MA; Foti ME
    J Clin Psychiatry; 1988 Sep; 49(9):333-7. PubMed ID: 3417618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liability to alprazolam abuse in daughters of alcoholics.
    Ciraulo DA; Sarid-Segal O; Knapp C; Ciraulo AM; Greenblatt DJ; Shader RI
    Am J Psychiatry; 1996 Jul; 153(7):956-8. PubMed ID: 8659624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human abuse potential of brivaracetam in healthy recreational central nervous system depressant users.
    Schoedel KA; Stockis A; Sellers EM
    Epilepsy Behav; 2018 Jan; 78():194-201. PubMed ID: 29153631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial.
    Levy-Cooperman N; Schoedel KA; Chakraborty B; Blum D; Cheng H
    Epilepsy Behav; 2016 Aug; 61():63-71. PubMed ID: 27315134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in pharmacodynamics of anxiolytics in abstinent alcoholic men: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone.
    Ciraulo DA; Barnhill JG; Ciraulo AM; Sarid-Segal O; Knapp C; Greenblatt DJ; Shader RI
    J Clin Pharmacol; 1997 Jan; 37(1):64-73. PubMed ID: 9048275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
    Evans SM; Troisi JR; Griffiths RR
    J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alprazolam absorption kinetics affects abuse liability.
    Mumford GK; Evans SM; Fleishaker JC; Griffiths RR
    Clin Pharmacol Ther; 1995 Mar; 57(3):356-65. PubMed ID: 7697954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the abuse liability of buspirone in recreational sedative users.
    Cole JO; Orzack MH; Beake B; Bird M; Bar-Tal Y
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):69-75. PubMed ID: 6130076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental alcoholism as a risk factor in benzodiazepine abuse: a pilot study.
    Ciraulo DA; Barnhill JG; Ciraulo AM; Greenblatt DJ; Shader RI
    Am J Psychiatry; 1989 Oct; 146(10):1333-5. PubMed ID: 2782481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abuse liability assessment of atomoxetine in a drug-abusing population.
    Jasinski DR; Faries DE; Moore RJ; Schuh LM; Allen AJ
    Drug Alcohol Depend; 2008 May; 95(1-2):140-6. PubMed ID: 18328639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of verapamil on morphine-induced euphoria, analgesia and respiratory depression in humans.
    Vaupel DB; Lange WR; London ED
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1386-94. PubMed ID: 8263800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do formulation differences alter abuse liability of methylphenidate? A placebo-controlled, randomized, double-blind, crossover study in recreational drug users.
    Parasrampuria DA; Schoedel KA; Schuller R; Silber SA; Ciccone PE; Gu J; Sellers EM
    J Clin Psychopharmacol; 2007 Oct; 27(5):459-67. PubMed ID: 17873677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.
    Mumford GK; Rush CR; Griffiths RR
    J Pharmacol Exp Ther; 1995 Feb; 272(2):570-80. PubMed ID: 7853170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of alprazolam: a review.
    Huybrechts I
    Clin Ther; 1991; 13(1):100-17. PubMed ID: 2029716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men.
    Smith RB; Gwilt PR; Wright CE
    Clin Pharm; 1983; 2(2):139-43. PubMed ID: 6883942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital.
    Zawertailo LA; Busto UE; Kaplan HL; Greenblatt DJ; Sellers EM
    J Clin Psychopharmacol; 2003 Jun; 23(3):269-80. PubMed ID: 12826989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional magnetic resonance imaging of alprazolam-induced changes in humans with familial alcoholism.
    Streeter CC; Ciraulo DA; Harris GJ; Kaufman MJ; Lewis RF; Knapp CM; Ciraulo AM; Maas LC; Ungeheuer M; Szulewski S; Renshaw PF
    Psychiatry Res; 1998 May; 82(2):69-82. PubMed ID: 9754450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eysenck's personality dimensions and sex steroids in male abstinent alcoholics and nonalcoholics: an exploratory study.
    King AC; Errico AL; Parsons OA
    Biol Psychol; 1995 Feb; 39(2-3):103-13. PubMed ID: 7734625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single dose of prednisone does not induce amphetamine-like subjective effects in healthy subjects.
    Warot D; Danjou P; Payan C; Rocher J; Brialy N; Puech AJ
    Therapie; 1995; 50(4):307-12. PubMed ID: 7482385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.